Allogeneic Antibodies Identify GVL Targets CHAF1b and NuSAP1 in AML Patients.
Year: 2007
Type: article
Study design: Observational Study
Source: Blood
Institutions: Stanford Medicine, Stanford University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2562415006
